A citation-based method for searching scientific literature

Jai Min Ryu, Hee Jun Choi, Isaac Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, Doo Ho Choi, Yeon Hee Park, Jong-Won Kim, Jeong-Sun Seo, Jung-Hoon Park, Jeong Eon Lee, Sung-Won Kim. Breast Cancer Res Treat 2019
Times Cited: 5







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
40

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Ellen R Copson, Tom C Maishman, Will J Tapper, Ramsey I Cutress, Stephanie Greville-Heygate, Douglas G Altman, Bryony Eccles, Sue Gerty, Lorraine T Durcan, Louise Jones,[...]. Lancet Oncol 2018
126
40

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.
Anne-Renee Hartman, Rajesh R Kaldate, Lisa M Sailer, Lisa Painter, Charles E Grier, Robbin R Endsley, Marlena Griffin, Stephanie A Hamilton, Cynthia A Frye, Mark A Silberman,[...]. Cancer 2012
120
40

Brca1 controls homology-directed DNA repair.
M E Moynahan, J W Chiu, B H Koller, M Jasin. Mol Cell 1999
930
40

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
40

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
40

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
40

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
341
40

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
40


Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
20

Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
Zhishan Chen, Wanqing Wen, Jiandong Bao, Krystle L Kuhs, Qiuyin Cai, Jirong Long, Xiao-Ou Shu, Wei Zheng, Xingyi Guo. BMC Med Genomics 2019
13
20

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Emily K Law, Anieta M Sieuwerts, Kelly LaPara, Brandon Leonard, Gabriel J Starrett, Amy M Molan, Nuri A Temiz, Rachel Isaksson Vogel, Marion E Meijer-van Gelder, Fred C G J Sweep,[...]. Sci Adv 2016
94
20

A common deletion in the APOBEC3 genes and breast cancer risk.
Jirong Long, Ryan J Delahanty, Guoliang Li, Yu-Tang Gao, Wei Lu, Qiuyin Cai, Yong-Bing Xiang, Chun Li, Bu-Tian Ji, Ying Zheng,[...]. J Natl Cancer Inst 2013
96
20


Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.
Mohammad Hashemi, Abdolkarim Moazeni-Roodi, Mohsen Taheri. Asia Pac J Clin Oncol 2019
4
25

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
Serena Nik-Zainal, David C Wedge, Ludmil B Alexandrov, Mia Petljak, Adam P Butler, Niccolo Bolli, Helen R Davies, Stian Knappskog, Sancha Martin, Elli Papaemmanuil,[...]. Nat Genet 2014
178
20


Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wei Xiong Wen, Jaslyn Sian-Siu Soo, Pui Yoke Kwan, Elaine Hong, Tsung Fei Khang, Shivaani Mariapun, Christine Shu-Mei Lee, Siti Norhidayu Hasan, Pathmanathan Rajadurai, Cheng Har Yip,[...]. Breast Cancer Res 2016
26
20

APOBEC3B is an enzymatic source of mutation in breast cancer.
Michael B Burns, Lela Lackey, Michael A Carpenter, Anurag Rathore, Allison M Land, Brandon Leonard, Eric W Refsland, Delshanee Kotandeniya, Natalia Tretyakova, Jason B Nikas,[...]. Nature 2013
497
20

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.
Manikandan Periyasamy, Hetal Patel, Chun-Fui Lai, Van T M Nguyen, Ekaterina Nevedomskaya, Alison Harrod, Roslin Russell, Judit Remenyi, Anna Maria Ochocka, Ross S Thomas,[...]. Cell Rep 2015
54
20

Breast Cancer Immunotherapy: Facts and Hopes.
Leisha A Emens. Clin Cancer Res 2018
167
20

Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
Therese Phillips, Pauline Simmons, Hector D Inzunza, John Cogswell, James Novotny, Clive Taylor, Xiaoling Zhang. Appl Immunohistochem Mol Morphol 2015
127
20

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, S Wienert, G Van den Eynden, F L Baehner, F Penault-Llorca,[...]. Ann Oncol 2015
20

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.
Soley Bayraktar, Angelica M Gutierrez-Barrera, Diane Liu, Tunc Tasbas, Ugur Akar, Jennifer K Litton, E Lin, Constance T Albarracin, Funda Meric-Bernstam, Ana M Gonzalez-Angulo,[...]. Breast Cancer Res Treat 2011
64
20

Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
M Krainer, S Silva-Arrieta, M G FitzGerald, A Shimada, C Ishioka, R Kanamaru, D J MacDonald, H Unsal, D M Finkelstein, A Bowcock,[...]. N Engl J Med 1997
174
20

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Antonis Valachis, Andreas D Nearchou, Pehr Lind. Breast Cancer Res Treat 2014
63
20

Women age < or = 35 years with primary breast carcinoma: disease features at presentation.
Ana M Gonzalez-Angulo, Kristine Broglio, Shu-Wan Kau, Yesmin Eralp, Julie Erlichman, Vicente Valero, Richard Theriault, Daniel Booser, Aman U Buzdar, Gabriel N Hortobagyi,[...]. Cancer 2005
62
20

Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less.
Soley Bayraktar, Laura Amendola, Angelica M Gutierrez-Barrera, Syed S Hashmi, Chris Amos, Michael Gambello, Kaylene J Ready, Banu Arun. Breast 2014
14
20

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
343
20

Breast cancer survival in BRCA1 carriers.
D E Porter, M Dixon, E Smyth, C M Steel. Lancet 1993
37
20

Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
E Evron, A M Ben-David, H Goldberg, G Fried, B Kaufman, R Catane, M R Pfeffer, D B Geffen, P Chernobelsky, T Karni,[...]. Ann Oncol 2019
20
20

Population genetics of BRCA1 and BRCA2.
C I Szabo, M C King. Am J Hum Genet 1997
409
20

Unique features of young age breast cancer and its management.
Han-Byoel Lee, Wonshik Han. J Breast Cancer 2014
45
20

BRCA-associated breast cancer in young women.
M Robson, T Gilewski, B Haas, D Levin, P Borgen, P Rajan, Y Hirschaut, P Pressman, P P Rosen, M L Lesser,[...]. J Clin Oncol 1998
255
20

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
Mervi Laakso, Niklas Loman, Ake Borg, Jorma Isola. Mod Pathol 2005
129
20

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
J E Armes, L Trute, D White, M C Southey, F Hammet, A Tesoriero, A M Hutchins, G S Dite, M R McCredie, G G Giles,[...]. Cancer Res 1999
184
20

Therapeutic landscape in mutational triple negative breast cancer.
Yaqin Shi, Juan Jin, Wenfei Ji, Xiaoxiang Guan. Mol Cancer 2018
31
20

BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer.
D Turchetti, L Cortesi, M Federico, C Bertoni, L Mangone, S Ferrari, V Silingardi. Eur J Cancer 2000
27
20

Age at onset as an indicator of familial risk of breast cancer.
E B Claus, N J Risch, W D Thompson. Am J Epidemiol 1990
296
20


The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Guan-Tian Lang, Jin-Xiu Shi, Xin Hu, Chen-Hui Zhang, Ling Shan, Chuan-Gui Song, Zhi-Gang Zhuang, A-Yong Cao, Hong Ling, Ke-Da Yu,[...]. Int J Cancer 2017
44
20

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
50
20

The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Wen-Feng Li, Zhen Hu, Nan-Yan Rao, Chuang-Gui Song, Bin Zhang, Ming-Zhi Cao, Feng-Xi Su, Yong-Sheng Wang, Ping-Qing He, Gen-Hong Di,[...]. Breast Cancer Res Treat 2008
77
20

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences.
A Tutt, D Bertwistle, J Valentine, A Gabriel, S Swift, G Ross, C Griffin, J Thacker, A Ashworth. EMBO J 2001
322
20

Breast cancer in young women: an overview.
Zoi Anastasiadi, Georgios D Lianos, Eleftheria Ignatiadou, Haralampos V Harissis, Michail Mitsis. Updates Surg 2017
156
20

The spectrum of BRCA1 and BRCA2 mutations and clinicopathological characteristics in Chinese women with early-onset breast cancer.
Lili Chen, Fangmeng Fu, Meng Huang, Jinxing Lv, Wenzhe Zhang, Chuan Wang. Breast Cancer Res Treat 2020
3
33

Breast cancer in adolescents and young women.
C Shannon, I E Smith. Eur J Cancer 2003
103
20

Triple negative breast cancer: new therapeutic approaches and BRCA status.
Gamze Guney Eskiler, Gulsah Cecener, Unal Egeli, Berrin Tunca. APMIS 2018
22
20

Systemic treatment strategies for triple-negative breast cancer.
Budhi Singh Yadav, Suresh C Sharma, Priyanka Chanana, Swaty Jhamb. World J Clin Oncol 2014
71
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.